Qbiogene becomes part of MP Biomedicals

MP Biomedicals is pleased to announce the acquisition of Qbiogene creating a single world-class biomedical organization with the merger of life science and diagnostics product offerings. With the inclusion of Qbiogene products and expertise, MP Biomedicals has expanded its industry leading portfolio of products and solutions, and will continue to provide scientists and researchers with innovative tools and superior service.

MP Biomedicals is a global corporation headquartered in Irvine, California. MP Biomedicals has operations in Northern California, New York, Ohio, Japan (Tokyo), Belgium (Brussels), Germany (Eschwege), Australia (Seven Hills), Russia (Moscow) and Singapore. Now with the addition of Qbiogene, MP Biomedicals will also have offices in France (Strasbourg) and Canada (Montreal). For more information, visit www.mpbio.com or www.qbiogene.com.

Qbiogene is a global organization offering research products for all molecular biology researchers. Products include the BIO 101^® purification and media products, as well as innovative tools for transfection, PCR, gene delivery, protein expression, plant biotechnology, and all routine cloning procedures.

We will continue to provide all the support required in a partnership like business environment. Product and ordering information can be found online at qbiogene.com for Qbiogene products and mpbio.com for MP Biomedicals products. Qbiogene orders can be placed in the US at 800-854-0530 or Europe at 33 (0)3 88 67 54 25.

Lastly, we recognize that customers are the most important part of any business, and we would like to thank you for allowing us work with you in the past and look forward to a future of continued discovery together. If you would like to contact someone at Qbiogene regarding any issue, please send your inquiry to info@qbiogene.com.

Letter to Customers